Funding
Open Access funding enabled and organized by Projekt DEAL. The legal sponsor of the trial is the Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest (Steinbacher Hohl 2–26, 60488 Frankfurt am Main, Germany). The trial is supported by a research grant for conduction of the clinical trial and supply of study medication (ramucirumab in Arm A) by Lilly Deutschland GmbH. Lilly did not influence the content of this trial. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.